|
|
|
By Md. Saddam Nawaz, ACI HealthCare Ltd. | The FDA's new draft guidance emphasizes maintaining data integrity throughout bioavailability/bioequivalence studies and provides recommendations for applicants and testing site management. The public comment period ends either June 3 or July 3, depending on which FDA webpage you’re looking at. |
|
|
|
|
|
|
|
|
|
Drug Substance Or API Manufacturing | Pharma Expanse | Our network can support discovery, preclinical, clinical and commercial programs for NCEs. Review our network's API capabilities below and contact us to simplify your outsourcing solutions. |
|
|
Package Design Development Services | PCI Pharma Services | Our pharmaceutical packaging design department provides insightful packaging design and practical knowledge to deliver differentiated and cost-effective packaging solutions. |
|
|
Custom Chemical Synthesis | LAXAI | Leverage our technical expertise as well as our comprehensive facilities and equipment for robust support of your project's chemical synthesis requirements. |
|
|
OUTSOURCED PHARMA CAPACITY UPDATE |
|
|
|
CDMOs in biologics, cell and gene, and small molecule share their capabilities and available capacities. See for yourself why this virtual event has become a wildly popular resource to identify options for your development and manufacturing needs. |
|
|
Connect With Outsourced Pharma: |
|
|
|